budesonide

Budesonide is nebulized for maintenance and prophylactic treatment of asthma including patients who require oral corticosteroids and those who may benefit from a systemic dose reduction. It was initially patented in 1973. It sold under the brand name Pulmicort among others, is a medication of the corticosteroid type.. Reference standards of Budesonide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Budesonide (IPRS/244/12)-from IPC
    [catalogue_number] => PA IPIPRS 244 12
    [category_ids] => ,151,
    [chemical_name] => 
    [weight] => NA
    [form] => 
    [cas] => NA
    [pslug] => budesonide-iprs-244-12-paipiprs24412
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)